Does Melatonin Increase Blood Sugar? Essential Guide

Melatonin does not raise blood sugar in most healthy adults at typical doses. Research on sleep and glucose metabolism suggests the relationship is more complicated than a simple yes or no. Melatonin can affect insulin release and glucose handling in some people, and the effect depends on dose, timing, and individual biology.

What Is Melatonin and How Does It Work?

Melatonin is a hormone your brain produces in response to darkness. The pineal gland, a small structure near the center of the brain, releases it in the evening. This release is part of the body’s circadian system — the internal clock that governs sleep, body temperature, hormone cycles, and metabolism.

Melatonin levels typically begin rising a couple of hours before sleep and stay elevated through the night. Light exposure, especially in the blue spectrum, suppresses production. That is why screen use late at night can delay sleepiness in some people.

Melatonin supplements are synthetic versions of the hormone. In the US, they are sold as dietary supplements, not drugs. That means they are not held to the same manufacturing and purity standards as prescription medications. Doses in commercial products can vary from what the label states — sometimes substantially. A widely cited analysis found that melatonin content in supplements often did not match labeled amounts, with some products containing far more or less than declared.

The hormone also exists in the gut and other tissues, where it may play a role in digestion and energy regulation. This is an active area of research, but its clinical significance in humans is not fully established.

Does Melatonin Increase Blood Sugar?

For most healthy adults taking standard doses, melatonin does not meaningfully raise blood sugar. The evidence does not show a consistent increase in fasting glucose or A1c from typical supplement use.

But the picture changes depending on who is taking it and when. Melatonin receptors are present on pancreatic beta cells — the cells that release insulin. Some research suggests melatonin can influence insulin secretion, sometimes reducing it. In people with certain genetic variants of the MTNR1B gene, this effect appears stronger. Carriers of a specific variant have been linked to higher fasting glucose and a modestly increased risk of type 2 diabetes in some studies.

What does this mean in practice? For a person without diabetes taking melatonin occasionally for jet lag or shift work, the effect on blood sugar is likely small. For someone with type 2 diabetes or prediabetes, the interaction deserves more attention.

One area of genuine concern involves timing. Taking melatonin with a meal — rather than before bed — may impair glucose tolerance in some individuals. A small study published in a diabetes research journal found that melatonin taken shortly before an evening meal was associated with higher post-meal glucose in carriers of the MTNR1B risk variant. The study was small, and the finding has not been consistently replicated. It is a signal worth noting, not a settled conclusion.

The bottom line: melatonin is not a sugar-raising drug in the way that steroids or certain diuretics are. But it is not metabolically inert either.

How Does Melatonin Affect Insulin and Glucose Metabolism?

The relationship between melatonin and glucose metabolism runs in both directions. Melatonin receptors are found throughout the body, including in the pancreas, liver, and fat tissue. When melatonin binds to these receptors, it can influence how those tissues respond to insulin.

In the pancreas, melatonin appears to modulate insulin release. Some studies show it suppresses insulin secretion, particularly during the night when melatonin levels are naturally high. This may be part of the normal circadian rhythm — the body may be less efficient at processing glucose at night, which aligns with the fact that nighttime eating tends to produce higher blood sugar responses than the same food eaten earlier in the day.

In the liver, melatonin may affect glucose production. The liver releases glucose between meals to keep blood sugar stable. Melatonin signaling appears to influence this process, though the exact mechanisms are still being worked out.

There is also the question of sleep itself. Poor sleep and sleep disorders like obstructive sleep apnea are well-established risk factors for insulin resistance and type 2 diabetes. If melatonin improves sleep quality, that could indirectly support better glucose control. But if someone takes melatonin and stays awake anyway, or takes it at the wrong time and disrupts their circadian rhythm further, the metabolic effects could go the other way.

This is where the conversation gets nuanced. Melatonin is not simply “good” or “bad” for blood sugar. Its effects depend heavily on context.

Who Should Be Cautious About Melatonin and Blood Sugar?

People with diabetes or prediabetes should talk to their healthcare provider before using melatonin regularly. This is not because melatonin is known to cause dangerous blood sugar spikes, but because the interaction is not fully understood and individual responses vary.

Several groups warrant extra caution:

• People with type 2 diabetes — especially those with poorly controlled blood sugar or those taking insulin or sulfonylureas.
• People with the MTNR1B gene variant — this is not something most people know they have, but it is more common in certain populations.
• Shift workers — disrupted circadian rhythms already affect glucose metabolism, and adding melatonin at unusual times may complicate things further.
• People taking medications that affect blood sugar — including steroids, some antidepressants, and certain blood pressure medications.
• Pregnant or breastfeeding women — no clinical guidelines currently exist for melatonin use in these populations, and safety data are limited.

Children and adolescents should also be cautious. Melatonin is sometimes given to children for sleep issues, but long-term safety data are limited, and the hormonal effects during development are not well understood.

For anyone monitoring their blood sugar at home, checking levels after starting melatonin could provide useful personal data. If you notice a pattern of higher readings, that is worth discussing with your doctor.

What Does the Research Actually Show?

Research on melatonin and blood sugar is mixed. Some studies show no significant effect on glucose or insulin in healthy adults. Others show modest changes, particularly in people with certain genetic profiles or metabolic conditions.

A 2019 review of the evidence concluded that melatonin’s effects on glucose metabolism are complex and depend on factors like dose, timing, and individual genetics. The review did not find consistent evidence that melatonin supplements cause clinically significant blood sugar increases in healthy people.

Some smaller studies have found that melatonin may improve glycemic control in people with type 2 diabetes when taken at bedtime. Others have found no benefit or even slight worsening. The inconsistency suggests that melatonin is not a one-size-fits-all intervention.

One important limitation: most studies are short-term. We do not have large, long-term trials looking at whether years of melatonin use affects diabetes risk or glucose control. That evidence gap matters.

The supplement industry is also a factor. Because melatonin is not tightly regulated, the actual dose in a product may differ from what the label says. This makes it hard to draw firm conclusions from studies that rely on self-reported supplement use.

Practical Considerations for Melatonin Use

If you are considering melatonin for sleep and you have concerns about blood sugar, here are some points to keep in mind.

Timing matters. Taking melatonin close to a meal may affect glucose handling more than taking it before bed. If you are going to use it, separating it from food by at least a couple of hours may be prudent, though this has not been formally tested in large trials.

Dose matters. Many melatonin supplements contain far more than the body naturally produces. Lower doses — often in the range of 0.5 to 1 mg — may be as effective for sleep as higher doses, with potentially fewer systemic effects. This is a general observation from sleep research, not a specific recommendation for blood sugar management.

Monitor if you have diabetes. If you have diabetes and start melatonin, check your blood sugar more frequently for the first few weeks. Look for patterns rather than single readings.

Do not replace proven treatments. Melatonin is not a treatment for diabetes, prediabetes, or insulin resistance. It is a sleep aid. If you have concerns about your blood sugar, the established approaches — diet, exercise, medication as prescribed — remain the foundation.

Talk to your doctor. This is especially important if you take insulin, sulfonylureas, or other medications that can cause low blood sugar. The interaction between melatonin and these drugs has not been well studied.